RARRES1 antibody
Principal name
RARRES1 antibody
Alternative names for RARRES1 antibody
TIG1, Retinoic acid receptor responder protein 1, RAR-responsive protein TIG1, Tazarotene-induced gene 1 protein
SwissProt ID
P49788 (Human)
Gene ID
5918 (RARRES1)
Ncbi ID
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), ELISA (detection) (E(detection)), Immunocytochemistry/Immunofluorescence (ICC/IF), Paraffin Sections (P)
Background of RARRES1 antibody
This gene was identified as a retinoid acid (RA) receptor-responsive gene. It encodes a type 1 membrane protein. The expression of this gene is upregulated by tazarotene as well as by retinoic acid receptors. The expression of this gene is found to be downregulated in prostate cancer, which is caused by the methylation of its promoter and CpG island. Altertively spliced transcript variant encoding distinct isoforms have been observed. [provided by RefSeq, Jul 2008].
General readings
Kwong J., et al. (2005) J Cancer. 113:386-392.
Western Blot analysis of RARRES1 expression in transfected 293T cell line (H00005918-T01) by RARRES1 MaxPab polyclonal antibody.Lane 1: RARRES1 transfected lysate(32.34 KDa).Lane 2: Non-transfected lysate.
RARRES1 monoclonal antibody (M06), clone 2E2. Western Blot analysis of RARRES1 expression in HL-60(Cat # L014V1 ).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RARRES1 (RC205143, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RARRES1.
Anti-RARRES1 mouse monoclonal antibody (TA506083) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY RARRES1(RC205143).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RARRES1 (RC205143, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RARRES1.
Immunohistochemical staining of paraffin-embedded Carcinoma of Human bladder tissue using anti-RARRES1 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min, TA506084)
Immunohistochemical staining of paraffin-embedded Human Kidney tissue within the normal limits using anti-RARRES1 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min, TA506084)
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RARRES1 (RC205143, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RARRES1.
Western blot analysis of extracts (10ug) from 2 different cell lines by using anti-RARRES1 monoclonal antibody.(1:200)
Anti-RARRES1 mouse monoclonal antibody (TA506085) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY RARRES1(RC205143).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RARRES1 (RC205143, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RARRES1.
Western blot analysis of extracts (35ug) from 9 different cell lines by using anti-RARRES1 monoclonal antibody (HepG2: human; HeLa: human; SVT2: mouse; A549: human; COS7: monkey; Jurkat: human; MDCK: canine; PC12: rat; MCF7: human).
Immunohistochemical staining of paraffin-embedded Human Kidney tissue within the normal limits using anti-RARRES1 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min, TA506087)
Anti-RARRES1 mouse monoclonal antibody (TA506087) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY RARRES1(RC205143).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RARRES1 (RC205143, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RARRES1.
Anti-RARRES1 mouse monoclonal antibody (TA506088) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY RARRES1(RC205143).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RARRES1 (RC205143, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RARRES1.
Western blot analysis of extracts (35ug) from 9 different cell lines by using anti-RARRES1 monoclonal antibody (HepG2: human; HeLa: human; SVT2: mouse; A549: human; COS7: monkey; Jurkat: human; MDCK: canine; PC12: rat; MCF7: human).
Immunohistochemical staining of paraffin-embedded Human Kidney tissue within the normal limits using anti-RARRES1 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min, TA506089)
Immunohistochemical staining of paraffin-embedded Human pancreas tissue within the normal limits using anti-RARRES1 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min, TA506089)
Immunohistochemical staining of paraffin-embedded Carcinoma of Human bladder tissue using anti-RARRES1 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min, TA506089)
Anti-RARRES1 mouse monoclonal antibody (TA506089) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY RARRES1(RC205143).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RARRES1 (RC205143, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RARRES1.
Western blot analysis of extracts (10ug) from 8 different cell lines by using anti-RARRES1 monoclonal antibody.(1:200)
Immunohistochemical staining of paraffin-embedded Human Kidney tissue within the normal limits using anti-RARRES1 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min, TA506090)
Anti-RARRES1 mouse monoclonal antibody (TA506090) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY RARRES1(RC205143).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RARRES1 (RC205143, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RARRES1.
Anti-RARRES1 mouse monoclonal antibody (TA506091) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY RARRES1(RC205143).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RARRES1 (RC205143, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RARRES1.
Western blot analysis of extracts (10ug) from 1 cell lines by using anti-RARRES1 monoclonal antibody at 1:200 dilution.
Predicted band size: 26 kDa. Positive control: Human liver cancer tissue lysate. Recommended dilution: 1/500-2000. (Gel: %SDS-PAGE Lysate: 50 ug per lane Primary antibody: 1/300 dilution Secondary antibody: Goat anti Rabbit IgG - H&L (HRP) at 1/10000 dilution Exposure time: 40 seconds)
Predicted cell location: Cytoplasm . Positive control: Human colon cancer tissue . Recommended dilution: 1/100-300 The image on the left is immunohistochemistry of paraffin-embedded human colon cancer tissue using RARRES1 antibody at dilution 1/60, on the right is treated with the synthetic peptide. (Original magnification:x200)
Predicted cell location: Cytoplasm . Positive control: Human cervical and colon cancer tissue . Recommended dilution: 1/100-300 The image on the left is immunohistochemistry of paraffin-embedded human cervical cancer tissue using RARRES1 antibody at dilution 1/60, on the right is treated with the synthetic peptide. (Original magnification:x 200)
Predicted cell location: Cytoplasm . Positive control: Human cervical and colon cancer tissue . Recommended dilution: 1/100-300 The image on the left is immunohistochemistry of paraffin-embedded human colon cancer tissue using RARRES1 antibody at dilution 1/60, on the right is treated with the synthetic peptide. (Original magnification:x200)
- Quick-Filters:
- Highly Validated (2)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA506084 | RARRES1 antibody |
||||||
| RARRES1 mouse monoclonal antibody, clone OTIB1 (formerly B1) | |||||||
 |
Mouse | IgG2b | OTIB1 | Purified | Hu | P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
 +3 additional images |
Highly validated antibody!
|
||||||
| TA506089 | RARRES1 antibody |
||||||
| RARRES1 mouse monoclonal antibody, clone OTID2 (formerly D2) | |||||||
 |
Mouse | IgG2b | OTID2 | Purified | Hu | ICC/IF, P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +5 additional images |
Highly validated antibody!
|
||||||
| TA322933 | RARRES1 antibody |
||||||
| Anti-RARRES1 Rabbit Polyclonal Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, P, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|||||||
| TA322934 | RARRES1 antibody |
||||||
| Anti-RARRES1 Rabbit Polyclonal Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, P |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|||||||
| TA506082 | RARRES1 antibody |
||||||
| RARRES1 mouse monoclonal antibody, clone OTI1C9 (formerly 1C9) | |||||||
 |
Mouse | IgG2b | OTI1C9 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
| TA506083 | RARRES1 antibody |
||||||
| RARRES1 mouse monoclonal antibody, clone OTI1A6 (formerly 1A6) | |||||||
 |
Mouse | IgG2b | OTI1A6 | Purified | Hu | ICC/IF, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|
||||||
| TA506085 | RARRES1 antibody |
||||||
| RARRES1 mouse monoclonal antibody, clone OTI2E12 (formerly 2E12) | |||||||
 |
Mouse | IgG2b | OTI2E12 | Purified | Hu | ICC/IF, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +2 additional images |
|
||||||
| TA506087 | RARRES1 antibody |
||||||
| RARRES1 mouse monoclonal antibody, clone OTIH2 (formerly H2) | |||||||
 |
Mouse | IgG2b | OTIH2 | Purified | Hu | ICC/IF, P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +2 additional images |
|
||||||
| TA506088 | RARRES1 antibody |
||||||
| RARRES1 mouse monoclonal antibody, clone OTI1B3 (formerly 1B3) | |||||||
 |
Mouse | IgG2b | OTI1B3 | Purified | Can, Hu, Mky, Ms, Rt | ICC/IF, WB |
0.1 ml /
€379.00
|
| OriGene Technologies, Inc. | |||||||
| +2 additional images |
|
||||||
| TA506090 | RARRES1 antibody |
||||||
| RARRES1 mouse monoclonal antibody, clone OTIA7 (formerly A7) | |||||||
 |
Mouse | IgG2b | OTIA7 | Purified | Hu | ICC/IF, P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +2 additional images |
|
||||||
| TA506091 | RARRES1 antibody |
||||||
| RARRES1 mouse monoclonal antibody, clone OTI1B8 (formerly 1B8) | |||||||
 |
Mouse | IgG2b | OTI1B8 | Purified | Hu | ICC/IF, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +2 additional images |
|
||||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY404197 | RARRES1 overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |